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Cases of acute myocardial infarction (AMI) that occur
during pregnancy or postpartum are rarely reported. Ergot
derivatives are known to induce the spasmodic contraction of
coronary arteries. Administration of ergot derivatives can cause
AMI, even in normal healthy people. In several reported cases,
ergot derivatives triggered severe AMI during the postpartum
period. Here, we report the case of a forty-year-old woman
who was successfully impregnated by artificial fertilization
and died after treatment with ergot derivatives. The autopsy
revealed AMI with severe coronary atherosclerosis. This is the
first case that reports aggravation of pre-existent severe coro-
nary atherosclerosis after postpartum infusion of ergot deriv-
tives.
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INTRODUCTION
Acute myocardial infarction (AMI) that occurs
during pregnancy or postpartum is very rare.
1-3
Since 1922, few cases have been reported. Ergot
derivatives are known to induce the spasmodic
contraction of coronary arteries
4 and are also used
to diagnose ischemic heart diseases during car-
diac catheterization.
5 Use of these ergot deriv-
atives can cause acute AMI in normal, healthy
people.
6 Ergot derivatives are infused to induce
contraction of the uterus after a cesarean section.
The infusion of these reagents causes severe AMI
during the postpartum period.
7-12 We examined a
forty-year- old woman who was successfully
impregnated via artificial fertilization. She died
after ergot derivatives were administered. The
autopsy showed a case of AMI with severe
coronary atherosclerosis.
CASE REPORT
Due to infertility, a 40-year-old woman visited
a local obstetric clinic and was impregnated via
artificial fertilization. This was the first pregnancy
for the woman, and she visited the clinic once a
week to get a prenatal diagnosis after thirty-six
weeks of gestation. At the thirty-eighth week, she
was admitted to the clinic because of a low-lying
placenta. Admission electrocardiograph (ECG)
records showed abnormal findings, including
right ventricular hypertrophy, right atrial enlarge-
ment, and right electrical axis deviation (Fig. 1A).
The delivery was performed by general anes-
thesia with N2O and ethrane. Due to the loss of
approximately 1,500 mL blood, two pints of blood
were supplied during the operation. She gave
birth to a healthy boy who weighed approxi-
mately 3.8 kilograms. After the delivery, she
received one ample of ergot derivatives (proprie-
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tary name: eruvin). However, her postoperative
ECG showed doubtable signs of ischemic heart
disease (Fig. 1B). She was transferred to an emer-
gency room (ER) of a general hospital. The medi-
cal records showed: systolic blood pressure of 96
mmHg, pulse of 92 beats/min, 21 respirations/
min, and a body temperature of 37.2 . She
started to complain about chest pain, and the
ECG showed an acute myocardial infarction of
the inferior wall. Additionally, the analysis of
cardiac enzymes showed following findings: 162
U/L CK, 221 U/L CK-MB, 530 U/L LDH, and
negative Troponin-T. Although these results were
compatible with an acute myocardial infarction,
she received sufficient amounts of fluid and
nitroglycerin due to her hypovolemic state and
acute MI. Five minutes later she showed an
abrupt convulsion of a generalized type and lost
consciousness. Cardiac arrest occurred, and cardi-
opulmonary resuscitation with intubation for one
hour could not save her. She did not have any
genetic or cardiac diseases, or any other risk fac-
tors for coronary atherosclerosis such as diabetes
mellitus, smoking, hyperlipidemia, or a hyperten-
sive disorder. The artificial fertilization was the
only medical history.
Autopsy findings
She was approximately 162 cm tall and weighed
65 kg. The external examination revealed CPR
marks on her chest, a lower abdominal operative
scar, several injection marks, and a small amount
of vaginal bleeding from the deceased body.
Internally, the heart weighed about 388.0 g, which
is heavier than the normal range (Fig. 2). Gross
and histological examinations revealed that the
right coronary artery, left anterior descending
branch of left coronary artery, and the left circum-
flex artery were hardened by severe athero-
sclerosis and calcification. An obstructive vascular
lumen was also found (Fig. 3). The liver weighed
about 1,985 g, and showed partial fatty degenera-
Fig. 1. 12-lead ECGs before (A) and after (B) the opera-
tion. A) A surface ECG shows sinus tachycardia (105
eats/min). Right axis deviation (RAD) and increased R/S
ratio in lead V1 suggest right ventricular hypertrophy. B)
A surface ECG shows a similar rate of sinus tachycardia
and RAD. ST elevations (arrows) are noted in limb leads
II, III, aVF. ST depressions (arrow heads) in precordial
leads (V1-2) suggest acute infero-posterior myocardial
infarction.
Fig. 3. Left anterior descending coronary artery is near-
totally obstructed by atherosclerosis with calcification.
Fig. 2. Heart weighs about 388 g and shows flabby
appearance.
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tion. There was no indication of any specific dis-
ease or injury. No toxic agents or alcohol com-
ponents were detected in the blood or gastric
contents.
DISCUSSION
Acute myocardial infarction rarely occurs in
women of child-bearing age, the frequency of
AMI among pregnant women is approximately 1
in 10,000.
1 Premenopausal women without risk
factors such as diabetes mellitus, hyperlipidemia,
and severe hypertension have rarely AMI or
coronary atherosclerosis.
13 Since the first report
was published in 1922,
2 few cases have been
reported.
3 In 1996, Roth and Elkayam
3 reported
125 cases of pregnancy-related AMI, which had
serious effects on the prognosis of pregnant
women as well as neonates. This study revealed
that the AMI occurrence rate tends to increase in
old-aged pregnancy (more than 35 years old,
WHO), and with smoking, stress, and drug addic-
tion. All pregnant women are at risk of AMI, but
it is mostly seen in women older than 33 years
who are in their third trimester. Additionally, the
occurrence rate in multiparous women is higher
than in primiparas. AMI chiefly invades the ante-
rior wall of the left ventricle. The maternal death
rate is approximately 21%, and usually occurs
within two weeks of onset. Although the fetal
death rate is usually closely related to maternal
death rate, it is 13% in the case of AMI. Apart
from thrombus formation, morphological findings
have demonstrated coronary atherosclerosis in
42% of all pregnant women and 29% in normal
coronary arteries. In our case, the deceased
woman has had no risk factors except old age.
However, all three major coronary arteries were
95% obstructed with atherosclerosis. A partial
calcification was also observed. A histological
examination showed no infarction, but an EKG
revealed infarction of the inferior wall.
Ergot derivatives have usually been used to
treat migraines. This medicine is also widely used
in the obstetric field as an oxytoxic agent after
delivery. Although a person with a cardiac disease
is a contraindication for use of this medicine, there
are relatively few cardiac complications. Additio-
nally, since ischemic changes in cardiac muscle
after an ergot derivative-induced delivery are very
rare, anesthesiologists are apt to overlook a pos-
sible occurrence of the ischemia. Anesthesiological
reports which discuss AMI are rare. On the other
hand, approximately seven cases of ergot deriva-
tive-related AMI after delivery have been reported
in obstetrics or heart-related journals.
7-12 Ergot
derivatives are known to reduce the capacity of
the intravascular lumen by 15-20% in normal
coronary arteries.
5 The pathogenesis of arterial
spasms strong enough to induce myocardial in-
farction is uncertain. However, known risk factors
are: old-aged pregnancy (over 30 years old),
smoking, alcohol abuse, and a past medical
history of migraines.
8-12 Recent reports have indi-
cated that AMI rates among Asians are higher
than in Caucasians and Blacks.
14 In conclusion, it
is reasonable to postulate that the infusion of
ergot-derivatives induces AMI, although this
medicine is commonly used.
To date, ergot derivatives have been commonly
used to induce uterine contractions without con-
sidering AMI. Our report is the first that refers to
a pregnant woman who died with a severe aggra-
vation of AMI after the administration of ergot-
derivatives. Overall, cardiac problems in pregnant
women should be always checked before delivery,
especially in cases artificial fertilization in old-
aged women. All pregnant women with several
risk factors need to be carefully monitored for
AMI; the person in charge of drug selection
should always be alert and pay attention.
REFERENCES
1. Hankins GD, Wendel GD Jr, Leveno KJ, Stoneham J.
Myocardial infarction during pregnancy: a review.
Obstet Gynecol 1985;65:139-46.
2. Sullivan JM, Ramanathan KB. Management of medical
problems in pregnancy- severe cardiac disease. N Engl
J Med 1985;313:304-9.
3. Roth A, Elkayam U. Acute myocardial infarction
associated with pregnancy. Ann Intern Med 1996;125:
751-62.
4. De Groot AN, van Dongen PWJ, Vree TB, Hekster YA,
van Roosmalen J. Ergot alkaloids. Current status and
review of clinical pharmacology and therapeutic use
compared with other oxytocics in obstetrics and
gynaecology. Drugs 1998;56:523-35.AMI Associated with Ergot Alkaloids Administration
Yonsei Med J Vol. 46, No. 6, 2005
5. Lange RA, Hillis LD. Assessment of cardiovascular
function, Diagnostic and therapeutic cardiac catheteri-
zation, 2nd ed. Baltimore: Williams & Wilkins; 1994. p.
394-429.
6. Nall KS, Feldman B. Postpartum myocardial infarction
induced by methergine. Am J Emerg Med 1998;16:502-
4.
7. Tsui BC, Stewart B, Fitzmaurice A, Williams R. Cardiac
arrest and myocardial infarction induced by post-
partum intravenous ergonovine administration. Anes-
thesiology 2001;94:363-4.
8. Taylor G, Cohen B. Ergonovine-induced coronary
artery spasm and myocardial infarction after normal
delivery. Obstet Gynecol 1985;66:821-2.
9. Liao JK, Cockrill BA, Yurchak PM. Acute myocardial
infarction after ergonovine administration for uterine
bleeding. Am J Cardiol 1991;68:823-4.
10. Fujiwara Y, Yamanaka O, Nakamura T, Yokoi H,
Yamaguchi H. Acute myocardial infarction induced by
ergonivine administration for artificially induced abor-
tion. Jpn Heart J 1993;34:803-8.
11. Ko WJ, Ho HN, Chu SH. Postpartum myocardial
infarction rescued with an intraaortic balloon pump
and extracorporeal membrane oxygenator. Int J Cardiol
1998;63:81-4.
12. Yaegashi N, Miura M, Okamura K. Acute myocardial
infarction associated with postpartum ergot alkaloid
administration. Int J Gynecol Obstet 1999;64:67-8.
13. Kumar V, Abbas AK, Fausto N. Pathologic basis of
disease. 7th ed. Philadelphia: Elsevier Saunders; 2004.
p.520.
14. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R,
Fujita M, Mongiardo R, et al. Major racial differences
in coronary constrictor response between Japanese and
Caucasians with recent myocardial infarction. Circu-
lation 2000;101:1102-8.